SEP-0372814 Inhibitor

Name: SEP-0372814 Inhibitor; MyBioSource
Brand: MyBioSource
SKU: MBS5751821
Availability: InStock
Rating: 5 (10 reviews)

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5751821

PDE10-IN-1 is PDE10-IN-1 inhibitor extracted from Patent WO 2013192273 A1, for treating CNS and metabolic disorders. More details

Please Inquire

Product Documentation

Sample Manual Insert View PDF

Testing Data View PDF

Certificate of Analysis (COA) View PDF

QC Report View PDF

Material Safety Data Sheet View PDF

Technical Datasheet View PDF

Protocol View PDF

Product Overview

Online Datasheet in PDF

Product Name

SEP-0372814, Inhibitor

Full Product Name

SEP-0372814

Product Gene Name

SEP-0372814, inhibitor

Form/Format

Powder

Purity/Purification

98.00%

Preparation and Storage

Store at -20 degree C for 3 years powder; -80 degree C for 2 years in solvent
For obtaining a higher solubility, please warm the tube at 37 degree C and shake it in the ultrasonic bath for a while. Stock solution can be stored below -20 degree C for several month.

Molecular Weight

350.42

Formula

C23H18N4

CAS

1516896-09-5

Smiles

Cc1c(nc2c3cccnc3ccn12)[C@@H]1C[C@H]1c1nc2c(C)ncc(C)n2n1

Solubility

DMSO: 2mg/mL (5.41mM)
(<1mg/ml refers to the product slightly soluble or insoluble)

Product Categories/Family for SEP-0372814, inhibitor

Home; Metabolism; PDE

Product References and Citations for SEP-0372814, inhibitor

1. Campbell, John Emmerson, et al. Preparation of heteroaryl compounds as PDE-10 inhibitors for treating CNS and metabolic disorders. Patent WO 2013192273 A1 20131227.

Other Notes

Small volumes of SEP-0372814, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for SEP-0372814 purchase

MBS5751821 is an inhibitor targeting SEP-0372814.